News for Your Practice

Risk of 3 types of ovarian cancer higher in women who have endometriosis

Author and Disclosure Information

A team of researchers reports that women who have a history of endometriosis are significantly more likely to develop clear-cell, endometrioid, or low-grade serous ovarian Ca—compared with women who have never had endometriosis


 

References

Several small studies have suggested that endometriosis—which affects about 10% of women of reproductive age—is a risk factor for epithelial ovarian cancer. Now, a study published online in Lancet Oncology provides definitive evidence of this link and highlights the risk of specific subtypes of ovarian cancer.1

In the study, a team from the Ovarian Cancer Association Consortium calculated the size of the association between endometriosis and each of the five major ovarian cancer histologic subtypes:

  • high-grade serous (odds ratio [OR], 1.13; 95% confidence interval [CI], 0.97–1.32; P = .13)
  • low-grade serous (OR, 2.11; 95% CI, 1.39–3.20; P < .0001)
  • clear-cell (OR, 3.05; 95% CI, 2.43–3.84; P < .0001)
  • endometrioid (OR, 2.04; 95% CI, 1.67–2.48; P < .0001)
  • mucinous carcinomas (OR, 1.02; 95% CI, 0.69–1.50; P = .93).

The study consisted of a pooled analysis of 13 case-control studies, which included data from more than 23,000 women (13,326 controls; 7,911 women who had invasive ovarian cancer; and 1,907 women who had borderline cancer).

A history of endometriosis more than tripled the risk of clear-cell ovarian cancer and more than doubled the risk of endometrioid tumors. It also doubled the risk of low-grade serous ovarian cancers.

A link was not found between endometriosis and high-grade serous, mucinous, serous borderline, or mucinous borderline ovarian cancers.

The authors of the published report of the study characterize their findings as a “breakthrough” that “could lead to better identification of women at increased risk of ovarian cancer and could provide a basis for increased cancer surveillance of the relevant population, allowing better individualization of prevention and early detection approaches such as risk-reduction surgery and screening,” according to Celeste Leigh Pearce from the University of Southern California, Los Angeles, the lead author.

But the authors were quick to offer a caution: “Although we have reported strong associations between endometriosis and risk of clear-cell, endometrioid, and low-grade serous ovarian cancers, most women with endometriosis do not develop ovarian cancer. However, health-care providers should be alert to the increased risk of specific subtypes of ovarian cancer in women with a history of endometriosis.”

We want to hear from you! Tell us what you think.

Recommended Reading

What is optimal surveillance after treatment for high-grade cervical intraepithelial neoplasia (CIN)?
MDedge ObGyn
Cancer survivors have many complaints not addressed by their physicians
MDedge ObGyn
Can a novel risk-scoring system for ovarian cancer predict who is most likely to develop disease?
MDedge ObGyn
“Does cancer cause menorrhagia?” A lament on the decline of the art of medicine
MDedge ObGyn
ACOG recommends that annual screening mammograms begin at age 40
MDedge ObGyn
UPDATE ON SEXUAL DYSFUNCTION
MDedge ObGyn
Daughters whose mothers are known carriers of genetic breast cancer are anxious and uninformed
MDedge ObGyn
Radiotherapy halves the rate of recurrence after breast-conserving cancer surgery
MDedge ObGyn
What is the recommended approach to a breast mass in a woman younger than 25 years?
MDedge ObGyn
MRI isn’t of much benefit to women with breast cancer—despite a rise in its use
MDedge ObGyn